Before a new medicine enters the market, it needs to be tested for its safety and efficacy in humans during so-called clinical trials. This process typically takes up to 10 years and has become increasingly complex, lengthy, and resource-inefficient. Triall's core mission is to accelerate society's access to safe and affordable medicines by making clinical trials smarter, safer, and more-efficient. We develop targeted blockchain-enabled solutions for data integrity, auditability, and operational efficiency that will gradually shape a multi-sided platform for clinical trial stakeholders: the Triall ecosystem.

If you are a Fund Manager or qualified investor interested in learning more about this project, you can interact with or follow it here:

Triall

Blockchain
Founded
2017
Crowdfunding
Stage
Default
Series
General
Before a new medicine enters the market, it needs to be tested for its safety and efficacy in humans during so-called clinical trials. This process typically takes up to 10 years and has become increasingly complex, lengthy, and resource-inefficient. Triall's core mission is to accelerate society's access to safe and affordable medicines by making clinical trials smarter, safer, and more-efficient. We develop targeted blockchain-enabled solutions for data integrity, auditability, and operational efficiency that will gradually shape a multi-sided platform for clinical trial stakeholders: the Triall ecosystem.
Team
Raymond van der Waal
Head of Marketing
Joost Flach
Head of Clinical Affairs
Mark van der Waal
Head of Design
Hadil Es-Sbai
CEO